These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 6205841)
1. Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications. Potter WZ Drugs; 1984 Aug; 28(2):127-43. PubMed ID: 6205841 [TBL] [Abstract][Full Text] [Related]
2. Biogenic amines and depression. The potential value of biochemical parameters in the diagnosis and medication of affective disorders. Ridges AP Postgrad Med J; 1976; 52(3 suppl):9-17. PubMed ID: 785425 [No Abstract] [Full Text] [Related]
3. Biogenic amine hypotheses of affective disorders. Garver DL; Davis JM Life Sci; 1979 Jan; 24(5):383-94. PubMed ID: 372718 [No Abstract] [Full Text] [Related]
4. A clinical perspective on the role of neurotransmitters in mental disorders. Brown RP; Mann JJ Hosp Community Psychiatry; 1985 Feb; 36(2):141-50. PubMed ID: 2579012 [TBL] [Abstract][Full Text] [Related]
5. The nonselective effect of selective antidepressants. Montgomery SA Adv Biochem Psychopharmacol; 1982; 32():49-55. PubMed ID: 6178265 [No Abstract] [Full Text] [Related]
8. Two noradrenergic systems in the brain and their interactions with other monoaminergic neurons. Kostowski W Pol J Pharmacol Pharm; 1979; 31(4):425-36. PubMed ID: 42889 [TBL] [Abstract][Full Text] [Related]
9. Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Maas JW Arch Gen Psychiatry; 1975 Nov; 32(11):1357-61. PubMed ID: 1200759 [TBL] [Abstract][Full Text] [Related]
10. The biological substrates of abnormal mental states. Kety SS Fed Proc; 1978 Jul; 37(9):2267-70. PubMed ID: 26608 [No Abstract] [Full Text] [Related]
11. Monoaminergic mechanisms in affective disorders. Syvälahti E Med Biol; 1987; 65(2-3):89-96. PubMed ID: 2888934 [TBL] [Abstract][Full Text] [Related]
12. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders]. Anokhina IP; Gamaleia NB Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209 [No Abstract] [Full Text] [Related]
13. Evaluation of role of the biogenic amines in affective illness: a clinical strategy. Prakash R Med Hypotheses; 1982 Jul; 9(1):51-3. PubMed ID: 6215558 [No Abstract] [Full Text] [Related]
15. Neurotransmitter hypotheses of depression. Research update. Jimerson DC Psychiatr Clin North Am; 1984 Sep; 7(3):563-73. PubMed ID: 6207513 [TBL] [Abstract][Full Text] [Related]
16. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity? Scheinin M Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215 [TBL] [Abstract][Full Text] [Related]
17. Sensation seeking, mania, and monoamines. Zuckerman M Neuropsychobiology; 1985; 13(3):121-8. PubMed ID: 4047373 [TBL] [Abstract][Full Text] [Related]
18. A multidimensional approach to analysis of cerebrospinal fluid biogenic amines in schizophrenia: I. Comparisons with healthy control subjects and neuroleptic-treated/unmedicated pairs analyses. Issa F; Gerhardt GA; Bartko JJ; Suddath RL; Lynch M; Gamache PH; Freedman R; Wyatt RJ; Kirch DG Psychiatry Res; 1994 Jun; 52(3):237-49. PubMed ID: 7991718 [TBL] [Abstract][Full Text] [Related]
19. The effects of psychopharmacological agents on central nervous system amine metabolism in man. Maas JW Annu Rev Pharmacol Toxicol; 1977; 17():411-24. PubMed ID: 17358 [No Abstract] [Full Text] [Related]
20. Role of serotonin in the behavioral and psychological symptoms of dementia. Lanctôt KL; Herrmann N; Mazzotta P J Neuropsychiatry Clin Neurosci; 2001; 13(1):5-21. PubMed ID: 11207325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]